Engineering ROS-scavenging Prussian blue nanozymes for efficient atherosclerosis nanotherapy

Prussian blue nanozymes were fabricated for atherosclerosis nanotherapy, which could reduce cellular reactive oxygen species level and exert cytoprotective effects against macrophages apoptosis, significantly boycotting atherosclerosis development.